The Cancer Letter

Inside information on cancer research and drug development

TCL Archive

Chemical Industry Sues NTP Over Listing PDC As Carcinogen; Environmental Groups Join Defense

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

YOU MAY BE INTERESTED IN

White House

White House to appoint Monica Bertagnolli as 16th NCI director

President Joe Biden has announced his intent to appoint Monica Bertagnolli as the 16th director of the National Cancer Institute—and the first woman and first chair of a clinical trials cooperative group to be named to the role.The White House announcement Aug. 10 comes nearly three weeks after news of Bertagnolli’s appointment leaked out on Twitter and in the press (The Cancer Letter, July 21, 2022).
By Matthew Bin Han Ong
Guest Editorial

How you can help Ukrainian oncology practitioners fight two evils: cancer and war

Can you imagine, as a radiation oncologist, you have to shelter your patients in a Co-60 vault to protect them from missiles, provide them with water by melting snow, feed them, keep them warm by using a backup power generator, and evacuate them just two hours before the missile destroys the radiation oncology department? 
By Nataliya Kovalchuk, Andriy Beznosenko, Ruslan Zelinsky, Nelya Melnitchouk, Viktor Iakovenko, Roman Kowalchuk, Oleh Duda, Andrii Hanych, Yuliia Severyn, Bohdana Bachynska, Serhii Brovchuk and Natalka Suchowerska
Guest Editorial

Patient navigation improves outcomes and addresses health equity across the cancer continuum

Research shows that cancer patients who receive navigation have improved survival, access to advanced care like clinical trials, and services like genetic testing and palliative care. Navigation often results in increased screening and patients receiving treatment sooner, resulting in improved quality of life and more cancer-free days.
By Arif Kamal and Tawana Thomas Johnson

Login

Looking for IP Login?